Page last updated: 2024-08-23

raloxifene hydrochloride and Pelvic Floor Diseases

raloxifene hydrochloride has been researched along with Pelvic Floor Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, B; Lee, JH; Polan, ML; Wen, Y1

Other Studies

1 other study(ies) available for raloxifene hydrochloride and Pelvic Floor Diseases

ArticleYear
The effect of raloxifene, a SERM, on extracellular matrix protein expression of pelvic fibroblasts.
    International urogynecology journal, 2012, Volume: 23, Issue:3

    Topics: Aged; Blotting, Western; Cells, Cultured; Collagen Type I; Collagen Type III; Drug Evaluation, Preclinical; Electrophoresis, Polyacrylamide Gel; Extracellular Matrix Proteins; Female; Fibroblasts; Humans; Matrix Metalloproteinases; Middle Aged; Pelvic Floor Disorders; Polymerase Chain Reaction; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tissue Inhibitor of Metalloproteinases

2012